These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 27757923)
1. Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State. Wang D; Chen G; Ren L AAPS PharmSciTech; 2017 Jul; 18(5):1526-1535. PubMed ID: 27757923 [TBL] [Abstract][Full Text] [Related]
2. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement. Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809 [TBL] [Abstract][Full Text] [Related]
3. A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells. Cutrignelli A; Lopedota A; Denora N; Iacobazzi RM; Fanizza E; Laquintana V; Perrone M; Maggi V; Franco M J Pharm Sci; 2014 Dec; 103(12):3932-3940. PubMed ID: 25302947 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A. Ren L; Jing J; Chen G; Miao Y; Wei P J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809 [TBL] [Abstract][Full Text] [Related]
5. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins. Ali AA; Sayed OM Pharm Dev Technol; 2013; 18(5):1042-50. PubMed ID: 22206481 [TBL] [Abstract][Full Text] [Related]
7. Effect of mechanochemical inclusion of triamterene into sulfobutylether-β-cyclodextrin and its improved dissolution behavior. Maeda H; Shiobara R; Tanaka M; Kajinami A; Nakayama H Drug Dev Ind Pharm; 2021 Apr; 47(4):535-541. PubMed ID: 33185132 [TBL] [Abstract][Full Text] [Related]
8. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A. Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811 [TBL] [Abstract][Full Text] [Related]
9. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics. Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389 [TBL] [Abstract][Full Text] [Related]
10. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244 [TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
12. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics. Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800 [TBL] [Abstract][Full Text] [Related]
13. Inclusion complex of lurasidone hydrochloride with Sulfobutylether-β-cyclodextrin has enhanced oral bioavailability and no food effect. Wang J; Huang B; Dai J; Chen G; Ren L Am J Transl Res; 2022; 14(3):1495-1506. PubMed ID: 35422944 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
15. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro cytotoxicity study of dronedarone hydrochloride inclusion complexes. Marcolino AIP; Macedo LB; Nogueira-Librelotto DR; Fernandes JR; Bender CR; Wust KM; Frizzo CP; Mitjans M; Vinardell MP; Rolim CMB Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():48-61. PubMed ID: 30948084 [TBL] [Abstract][Full Text] [Related]
17. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132 [TBL] [Abstract][Full Text] [Related]
18. Preparation, Characterization, and Properties of Inclusion Complexes of Balofloxacin with Cyclodextrins. Ren X; Qian H; Tang P; Tang Y; Liu Y; Pu H; Zhang M; Zhao L; Li H AAPS PharmSciTech; 2019 Aug; 20(7):278. PubMed ID: 31396732 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin. Lu Y; Zhang T; Tao J; Ji G; Wang S Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204 [TBL] [Abstract][Full Text] [Related]
20. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Bhargava S; Agrawal GP Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]